CDC73	YLR418C	Pol II transcription elongation factor activity	RNA elongation from Pol II promoter	transcription elongation factor complex	YDL033C	YDR334W	YEL033W	YER084W	YER139C	YLR168C	YLR269C	YML012C-A	YNL140C	YNL198C	YPL182C	YPR084W	YCL037C	YOR089C	YCR077C	YOR080W	YNL025C	YEL031W	YER122C	YOR216C	YLR268W	YDR137W	YHL031C	YGL020C	YLR039C	YLR262C	YEL061C	YLR373C	YIL128W	YPL069C	YAL013W		accessory factor associated with RNA polymerase II by affinity chromatography		Mutations affect cell growth and the abundance of transcripts from a subset of genes
CTR9	YOL145C	Pol II transcription elongation factor activity*	transcription from Pol II promoter*	nucleus*	YGL019W	YHR012W	YGL244W	YOR123C	YIL094C	YJR138W	YIL035C	YOR039W	YOR061W	YLR418C	YBR279W	YGL130W	YOR326W	YGL207W	YJR091C	YAL040C		CTR9 is required for normal CLN1 and CLN2 G1 cyclin expression		Null mutant is viable, loses chromosomes and shows temperature sensitivity
DST1	YGL043W	positive transcription elongation factor activity	meiotic recombination*	nucleoplasm	YOR151C	YJR132W	YBR109C	YLR418C	YDL049C		Transcription elongation factor S-II<br>Meiotic DNA recombination factor	RNA polymerase II elongation factor|Transcription elongation factor S-II (TFIIS)|transcription elong	Null mutant is viable; reduced induction of DNA strand transfer; sensitivity to 6-azauracil
DTD1	YDL219W	hydrolase activity, acting on ester bonds	D-amino acid catabolism	cellular_component unknown	YDL047W	YGL070C		D-Tyr-tRNA(Tyr) deacylase	D-Tyr-tRNA(Tyr) deacylase	
ELA1	YNL230C	transcriptional elongation regulator activity	RNA elongation from Pol II promoter	transcription elongation factor complex	YER077C	YLR423C	YML056C	YNL132W	YLR196W	YPL093W	YHR052W	YPL004C	YGR090W	YGR103W	YKR081C	YDR496C	YOL041C	YLR136C	YDL014W	YPL012W	YEL030W	YGR086C	YPL001W	YDR381W	YKL172W	YDR194C	YMR049C	YJL141C	YOR272W	YOR017W	YLR432W	YFR001W	YJR091C		similar to mammalian elongin A, interacts with elongin C	elongin A transcription elongation factor	
ELC1	YPL046C	transcriptional elongation regulator activity	RNA elongation from Pol II promoter	transcription elongation factor complex	YJR052W		similar to mammalian elongin C, interacts with elongin A	elongin C transcription elongation factor	
ELP2	YGR200C	Pol II transcription elongation factor activity	regulation of transcription from Pol II promoter	transcription elongation factor complex	YPL086C	YLR384C	YPL101W	YHR187W	YJR127C	YNL271C	YJL020C	YER016W	YNL298W	YLR229C	YOR326W	YAL013W		ELongator Protein 2; 90kD subunit; has WD40 repeats	RNA polymerase II Elongator subunit	Null mutant is viable but grows slowly and shows slow adaptation to growth on new media; ts- (39 C);
ELP3	YPL086C	Pol II transcription elongation factor activity*	regulation of transcription from Pol II promoter	transcription elongation factor complex*	YGR200C	YNL271C	YJL020C	YLR229C	YER016W	YOR326W	YAL013W	YMR263W		elongator protein; histone and other protein acetyltransferase; has sequence homology to known HATs	RNA polymerase II Elongator subunit|histone acetyltransferase	Null mutant is viable but grows slowly and shows slow adaptation to growth on new media; ts- (39^*C)
ELP4	YPL101W	Pol II transcription elongation factor activity	regulation of transcription from Pol II promoter	cytoplasm*	YGR200C	YLR229C	YNL271C	YER016W	YOR326W	YAL013W	YDR126W		ELongator Protein 4; 50kD subunit. Homolog of ATPases, yet with substitutions of amino acids critica	RNA polymerase II Elongator protein subunit	Null: Slow adaptation to growth on new media; <br> ts- (39 oC); sensitive to 1 M NaCl; insensitive t
ELP6	YMR312W	Pol II transcription elongation factor activity	regulation of transcription from Pol II promoter	transcription elongation factor complex	YLR327C	YHR187W	YNL298W	YLR229C	YNL271C	YER016W	YLR200W	YGR078C	YNL153C	YEL003W	YML094W	YAL013W	YDR126W		ELongator Protein 6; 30kD subunit. Homolog of ATPases, yet with substitutions of amino acids critica	RNA polymerase II Elongator protein subunit	Null:Slow adaptation to growth on new media; <br> ts- (39 oC); sensitive to 1 M NaCl; insensitive to
IKI1	YHR187W	Pol II transcription elongation factor activity	regulation of transcription from Pol II promoter	transcription elongation factor complex*	YGR200C	YMR047C	YMR312W		RNA polymerase II Elongator associated protein		Null mutant is viable but is insensitive to pGLK killer toxin; zymotoxin resistant; slow growth; the
IKI3	YLR384C	Pol II transcription elongation factor activity*	regulation of transcription from Pol II promoter	transcription elongation factor complex*	YDR461W	YGR200C	YER016W	YLR418C	YGR229C	YAL013W	YDR126W		RNA polymerase II Elongator subunit		Null mutant is viable; insensitive to pGKL killer toxin; zymotoxin resistant; slow growth; thermo-se
IWS1	YPR133C	Pol II transcription elongation factor activity	RNA elongation from Pol II promoter	transcription elongation factor complex	YGR116W	YPR094W		Interacts with Spt6	involved in transcriptional elongation	Null: Null Mutant is Lethal.
LEO1	YOR123C	Pol II transcription elongation factor activity	transcription from Pol II promoter*	transcription elongation factor complex*	YOL131W	YDR456W	YOL145C	YGL244W	YBR058C	YDR508C	YMR240C	YJL168C	YLR418C	YLR085C	YLR103C	YDR363W	YLR113W	YAL013W	YPL181W	YMR263W		member of the RNA polymerase II-associated Paf1 complex		Null mutant is viable
PAF1	YBR279W	Pol II transcription elongation factor activity	RNA elongation from Pol II promoter	transcription elongation factor complex	YOL145C	YGL244W	YGL207W		RNA polymerase II-associated, nuclear protein that may serve as both a positive and negative regulat		Null mutant is viable but shows slow growth, temperature-sensitivity, abnormal cell morphology, and
RTF1	YGL244W	Pol II transcription elongation factor activity	transcription from Pol II promoter*	transcription elongation factor complex*	YHR009C	YBR081C	YOR123C	YJR060W	YIL035C	YLR418C	YBR279W	YOL145C	YOR319W	YJL168C	YLR039C	YLR262C	YJR070C	YLR085C	YPR135W	YHR191C	YCL016C	YLR103C	YPR159W	YAL013W	YMR263W		Directly or indirectly regulates DNA-binding properties of Spt15p, TATA box-binding protein, and rel	nuclear protein	Null mutant is viable and can suppress TATA box-binding protein mutants (SPT15) in an allele-specifi
SPT16	YGL207W	Pol II transcription elongation factor activity*	chromatin modeling*	nuclear chromatin*	YPR135W	YGL019W	YML069W	YIL035C	YOL145C	YOR061W	YLR418C	YBR279W	YGL130W	YOR039W	YGR163W	YOL054W	YDR225W	YDR247W	YOL006C	YDL164C	YNL102W		global regulator of transcription		suppression of Ty insertion mutations
SPT4	YGR063C	Pol II transcription elongation factor activity	regulation of transcription, DNA-dependent*	nucleus*	YDR404C	YML095C	YBL008W		Zn-finger protein, transcriptional regulator	transcriptional regulator|zinc finger protein	
SPT5	YML010W	Pol II transcription elongation factor activity	regulation of transcription, DNA-dependent*	nucleus*	YDL140C	YBR236C	YDR404C	YPR041W	YBL046W	YNL201C	YJR017C		transcription factor	transcription factor	Null mutant is inviable
SPT6	YGR116W	Pol II transcription elongation factor activity	regulation of transcription, DNA-dependent*	nucleus*	YGL019W	YIL035C	YOR061W	YIL126W	YPR133C	YAL021C		may be involved in transcription elongation by mediating interactions between RNA polymerase II and	interacts with histones, primarily histone H3, possesses nucleosome assembly activity|transcriptiona	Null mutant is inviable, spt6 mutations exhibit synthetic lethality in combination with spt4 or spt5
